Format

Send to

Choose Destination
Haematologica. 2020 Mar;105(3):610-622. doi: 10.3324/haematol.2019.218503. Epub 2019 Aug 14.

PIEZO1 activation delays erythroid differentiation of normal and hereditary xerocytosis-derived human progenitor cells.

Author information

1
EA4666 HEMATIM, Université Picardie Jules Verne, Amiens.
2
Service des Maladies du Sang, CHU Amiens, Amiens.
3
Unité de Thérapie Cellulaire, CHU Amiens, Amiens.
4
Service d'Hématologie Biologique, CHU Amiens.
5
Service de Pédiatrie Générale, CHU Bicêtre, AP-HP, Le Kremlin-Bicêtre.
6
Laboratoire d'Hématologie, CHU Rouen, Rouen.
7
Service d'Oncologie et d'Hématologie, Hôpital Saint Vincent de Paul, Lille.
8
Etablissement Français du Sang (EFS) de Normandie, Bois-Guillaume.
9
EA4667 Laboratoire de Physiologie Cellulaire et Moléculaire, Université Picardie Jules Verne, Amiens.
10
Laboratoire de Génétique Moléculaire, CHU Amiens, Amiens.
11
Laboratoire d'Hématologie, AP-HP, Le Kremlin-Bicêtre, France.
12
EA4666 HEMATIM, Université Picardie Jules Verne, Amiens garcon.loic@chu-amiens.fr.

Abstract

Hereditary xerocytosis is a dominantly inherited red cell membrane disorder caused in most cases by gain-of-function mutations in PIEZO1, encoding a mechanosensitive ion channel that translates a mechanic stimulus into calcium influx. We found that PIEZO1 was expressed early in erythroid progenitor cells, and investigated whether it could be involved in erythropoiesis, besides having a role in the homeostasis of mature red cell hydration. In UT7 cells, chemical PIEZO1 activation using YODA1 repressed glycophorin A expression by 75%. This effect was PIEZO1-dependent since it was reverted using specific short hairpin-RNA knockdown. The effect of PIEZO1 activation was confirmed in human primary progenitor cells, maintaining cells at an immature stage for longer and modifying the transcriptional balance in favor of genes associated with early erythropoiesis, as shown by a high GATA2/GATA1 ratio and decreased α/β-globin expression. The cell proliferation rate was also reduced, with accumulation of cells in G0/G1 of the cell cycle. The PIEZO1-mediated effect on UT7 cells required calcium-dependent activation of the NFAT and ERK1/2 pathways. In primary erythroid cells, PIEZO1 activation synergized with erythropoietin to activate STAT5 and ERK, indicating that it may modulate signaling pathways downstream of erythropoietin receptor activation. Finally, we studied the in-vitro erythroid differentiation of primary cells obtained from 14 PIEZO1-mutated patients, from 11 families, carrying ten different mutations. We observed a delay in erythroid differentiation in all cases, ranging from mild (n=3) to marked (n=8). Overall, these data demonstrate a role for PIEZO1 during erythropoiesis, since activation of PIEZO1 - both chemically and through activating mutations - delays erythroid maturation, providing new insights into the pathophysiology of hereditary xerocytosis.

PMID:
31413092
DOI:
10.3324/haematol.2019.218503
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center